A proposed executive order aimed at increasing White House influence over grant allocations at the National Institutes of Health (NIH) has reportedly been stalled due to bipartisan opposition. Senator Susan Collins (R-Maine), chair of the Appropriations Committee, indicated that the initiative is “looking dead” after expressing concerns to federal officials, including Office of Management and Budget (OMB) Director Russell Vought and NIH Director Jay Bhattacharya.
Details of the Proposal and Legislative Response
On Tuesday, Collins sent a letter to Vought and Bhattacharya, urging them to abandon the plan to establish a commission of political appointees who would have veto authority over NIH grant awards. Collins emphasized that this proposal would undermine the objective of funding biomedical research based solely on scientific merit rather than political considerations.
Several other lawmakers echoed Collins’ concerns, with some expressing relief at the apparent reversal of the administration’s approach. Senator Patty Murray (D-Wash.), vice chair of the Senate Appropriations Committee, criticized the need for public outcry to prevent what she described as an attempt by President Trump and Vought to damage the NIH and limit funding for critical research programs.
The initiative reportedly emerged from discussions at a recent Oval Office meeting, in which Vought raised issues regarding NIH funding decisions that he deemed inconsistent with the Trump administration’s objectives. It has been suggested that the administration aimed to exert tighter control over NIH grants to redirect funding, particularly targeting institutions like Harvard University.
This proposal is part of a broader pattern of attempts by the OMB to exert more stringent oversight over scientific funding. Previous proposals, including mandated upfront funding of NIH grants and attempts to change contract guidelines to diminish the role of peer review, have faced substantial pushback from Congress. Last year, Congress intervened to limit the OMB’s authority in this regard, ultimately increasing the NIH budget in response to proposed cuts.
Recent efforts from the OMB, including delays in approving NIH budgets and a temporary halt on funding allocations, have also raised concerns within the scientific community about political interference in research funding. Congressional members have consistently reacted against measures perceived as encroaching on the independence of scientific decision-making.
The White House has not yet commented on the situation or the challenges posed by Congressional members regarding the current proposal.
Why It Matters: The events surrounding the proposed executive order highlight ongoing tensions between federal policymaking and scientific research funding. The balance of power in shaping research direction and priorities remains a critical issue, particularly amid growing concerns regarding political influence on scientific integrity and public health.
